Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Haşlak F, Kılıç Könte E, Aslan E, Şahin S, Kasapçopur Ö. Type I Interferonopathies in Childhood. Balkan Med J 2023;40:165-174. [PMID: 37161741 PMCID: PMC10175883 DOI: 10.4274/balkanmedj.galenos.2023.2023-4-78] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Accepted: 04/26/2023] [Indexed: 05/11/2023] Open

For:	Haşlak F, Kılıç Könte E, Aslan E, Şahin S, Kasapçopur Ö. Type I Interferonopathies in Childhood. Balkan Med J 2023;40:165-174. [PMID: 37161741 PMCID: PMC10175883 DOI: 10.4274/balkanmedj.galenos.2023.2023-4-78] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Accepted: 04/26/2023] [Indexed: 05/11/2023] Open

Number

Cited by Other Article(s)

Haslak F, Kilic H, Sahin S, Hotaman B, Cebi NM, Yildiz M, Adrovic A, Gunalp A, Konte EK, Aslan E, Gul U, Akay N, Zindar Y, Ulug F, Guler S, Kiykim A, Aydemir S, Barut K, Saltik S, Cokugras HC, Kasapcopur O. Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient Cohort. J Rheumatol 2024;51:1208-1217. [PMID: 39089832 DOI: 10.3899/jrheum.2024-0294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/11/2024] [Indexed: 08/04/2024]

Affiliation(s)

Fatih Haslak F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Huseyin Kilic H. Kilic, MD, Y. Zindar, MD, F. Ulug, MD, S. Guler, MD, S. Saltik, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Neurology
Sezgin Sahin F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Busra Hotaman F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Nur Memnune Cebi F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Mehmet Yildiz F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Amra Adrovic F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Aybuke Gunalp F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Elif Kilic Konte F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Esma Aslan F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Umit Gul F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Nergis Akay F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Yilmaz Zindar H. Kilic, MD, Y. Zindar, MD, F. Ulug, MD, S. Guler, MD, S. Saltik, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Neurology
Fitnat Ulug H. Kilic, MD, Y. Zindar, MD, F. Ulug, MD, S. Guler, MD, S. Saltik, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Neurology
Serhat Guler H. Kilic, MD, Y. Zindar, MD, F. Ulug, MD, S. Guler, MD, S. Saltik, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Neurology
Ayca Kiykim A. Kiykim, MD, S. Aydemir, MD, H.C. Cokugras, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Allergy, and Immunology, Istanbul, Turkey
Sezin Aydemir A. Kiykim, MD, S. Aydemir, MD, H.C. Cokugras, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Allergy, and Immunology, Istanbul, Turkey
Kenan Barut F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology
Sema Saltik H. Kilic, MD, Y. Zindar, MD, F. Ulug, MD, S. Guler, MD, S. Saltik, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Neurology
Haluk C Cokugras A. Kiykim, MD, S. Aydemir, MD, H.C. Cokugras, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Allergy, and Immunology, Istanbul, Turkey
Ozgur Kasapcopur F. Haslak, MD, S. Sahin, MD, B. Hotaman, MD, N.M. Cebi, MD, M. Yildiz, MD, A. Adrovic, MD, A. Gunalp, MD, E. Kilic Konte, MD, E. Aslan, MD, U. Gul, MD, N. Akay, MD, K. Barut, MD, O. Kasapcopur, MD, Istanbul University-Cerrahpasa Cerrahpasa Medical School, Department of Pediatric Rheumatology;

Collapse

Mendonça LO, Frémond ML. Interferonopathies: From concept to clinical practice. Best Pract Res Clin Rheumatol 2024;38:101975. [PMID: 39122631 DOI: 10.1016/j.berh.2024.101975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2024] [Revised: 06/12/2024] [Accepted: 07/08/2024] [Indexed: 08/12/2024]

Raupov R, Suspitsin E, Preobrazhenskaya EV, Kostik M. Interferon type I signature associated with skin disease in juvenile dermatomyositis. Front Med (Lausanne) 2024;11:1214920. [PMID: 38420360 PMCID: PMC10899462 DOI: 10.3389/fmed.2024.1214920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2023] [Accepted: 01/29/2024] [Indexed: 03/02/2024] Open

Bahgat MM, Nadeem R, Nasraa MH, Amer K, Hassan WA, ELGarhy FM, Reda S, Abd-Elshafy DN. Proinflammatory Cytokine Profiles in Both Mild Symptomatic and Asymptomatic SARS-CoV-2-Infected Egyptian Individuals and a Proposed Relationship to Post-COVID-19 Sequela. Viral Immunol 2023;36:600-609. [PMID: 37831918 DOI: 10.1089/vim.2023.0060] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2023] Open

Abstract

Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection is associated with proinflammatory cytokine release as mediators of host antiviral response to the infection. Cytokine persistent elevation leads to post-Coronavirus disease-2019 (COVID-19) post-COVID-19 sequela (PCS) reported in about 60% of patients affecting individual's normal life after recovery. This study evaluates relationship of cytokines and chemokines pattern during and postinfection to PCS events. Serum samples collected from 82 individuals with symptomatic, asymptomatic, or no SARS-CoV-2 infection were classified as recently or formerly infected groups according to levels of anti-2019nCoV Immunoglobulin G/Immunoglobulin M. Levels of interleukin (IL)-1α, IL-1β, IL-6, IL-8, interferon alpha (IFN-α), tumor necrosis factor alpha (TNF-α), granulocyte macrophage colony-stimulating factor (GM-CSF), and monocyte chemoattractant protein-1 were assessed via ELISA for each individual. All asymptomatic groups showed nonsignificant differences in cytokines' levels than control group. Significant elevation of IFN-α, TNF-α, and GM-CSF levels were observed in recent symptomatic, while IFN-α and TNF-α levels were significant in former symptomatic groups. We observed an association between fever with IL-1α and IFN-α levels, fatigue with TNF-α and GM-CSF, dyspnea with IFN-α, TNF-α, and GM-CSF, and chest-wheezing with GM-CSF. Individuals were surveyed 12 months postsampling for PCS events. Among 35 responders to survey, 8 (22.8%) reported PCS events, 6 of which were females. Upon studying PCS events, IL-8, IFN-α, TNF-α, and GM-CSF levels showed significant elevation in active infection, that was not seen in a resolved state of infection. Cytokines patterns suggest that either a persistent elevation in levels or damage caused during infection contributes to PCS. Although with the limited sample size, our study emphasizes the importance to conduct medical approaches targeting the associated cytokines to improve the PCS symptoms.

Collapse